Clinical Lab Consulting Team
Greg Ingle
Chief Executive Officer
Mr. Ingle brings over 15 years of Information Technology and Healthcare experience to CLC, ranging from project management and product development to sales, marketing, and executive functions. Mr. Ingle has worked on complex database projects for the Unites States Department of Defense, US Customs, and Fortune 500 clients such as Dow Agro Science and Eli Lilly. Mr. Ingle turned his site to healthcare in 2011 and was at the forefront of the private practice EMR revolution, where he helped develop and implement several EMR platforms. Mr. Ingle was instrumental in taking his previous company, Kareo to the Forbes List as one of “America’s Most Promising Companies” in 2012 and 2013. As the Chief Executive Officer of Clinical Laboratory Consulting, LLC™, he oversees a staff of 70 consulting Pathologists, PhD’s, and Medical Technologists.
Phillip Gibbs, PhD
Chief Science Officer
Dr. Gibbs is an experienced biochemist and NRCC certified Toxicological Chemist. He graduated from the Massachusetts Institute of Technology with a Bachelor of Science in Chemical Engineering and Minor in Psychology, then earned his Doctorate of Philosophy in Biomedical Engineering at University of Houston in 2001. He performed his Postdoctoral Fellowship with the School of Chemical Engineering at the Georgia Institute of Technology in Atlanta, GA from March 2001 to June 2003, where he managed the laboratory and projects involving development of novel high-throughput screening methods, phage display, and directed evolution of enzymes for biocatalysis. Dr. Gibbs currently serves as the Managing Director at Decima Diagnostics, LLC in Atlanta, GA.
Dr. Gibbs founded the Stheno Corporation in Atlanta, GA, where he served as the Chief Science Officer (2003 to 2009) and developed analytical instrumentation for chiral analysis. From 1991-1994, he worked as a Research Engineer with Energy Biosystems Corporation (later ENCHIRA) in The Woodlands, TX. There, he developed a microbial biodesulfurization process for the petrochemical industry. Dr. Gibbs has also worked at Enmatix, Inc. in Kennesaw, GA as a Senior Research Scientist responsible for managing analytical core lab and developing/licensing new technology related to potential biorefinery product streams, and with Sigma-Aldrich Corporation as a Field Applications Specialist (2011 to 2014).
He has multiple publications in journals such as Protein Expression and Purification and Biotechnology Progress, and has acquired 10 patents for biochemical techniques. Dr. Gibbs’ honors include the Georgia Institute of Technology Business Plan Competition finalist, February, 2003; William H. Peterson Award for Best Poster Presentation. American Chemical Society, Division of Biochemical Technology, Mar.ch 30, 2000; Sigma Xi Research Award 1999 & 2000; and Shell Scholar 1997-2000.